A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

A review on bispecific antibody (blinatumomab) for the treatment of acute lymphoblastic leukemia

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2024.

Detaylı Bibliyografya
Yazar: Choki, Kinley
Diğer Yazarlar: Chowdhury, Namara Mariam
Materyal Türü: Tez
Dil:English
Baskı/Yayın Bilgisi: Brac University 2024
Konular:
Acute lymphoblastic leukemia
Leukemia
R/R B-cell precursor ALL
FDA
Blood cancer
Lymphoblastic leukemia.
Cancer > Immunotherapy.
Monoclonal antibodies > Therapeutic use.
Online Erişim:http://hdl.handle.net/10361/24298

Internet

http://hdl.handle.net/10361/24298

Benzer Materyaller